We are proud to share that our work on cryopreserved hematopoietic organoids (CRYONOIDS) has been recognized at the upcoming ISSCR 2026 Annual Meeting in Montréal, where our abstract, “Cryopreserved hematopoietic organoids for distributed and bioreactor-agnostic immune cell manufacturing,” has been selected for both a Travel Award and a Merit Award by the International Society for Stem Cell Research. These awards highlight the significance of our approach to enabling scalable, uncouple, flexible immune cell production platforms. We look forward to presenting our findings, engaging with the international stem cell community, and contributing to ongoing discussions on next-generation cell manufacturing technologies.